Software based approaches for drug designing and development: A systematic review on commonly used software and its applications
Authors:
- Prasad G. JamkhandePJPrasad G. Jamkhande
- Mahavir H. GhanteMGMahavir H. Ghante
- Balaji R. AjgundeBABalaji R. Ajgunde
Open Access
- 1 December 2017
- journal article
- review article
- Published by Faculty of Pharmacy Cairo University in Bulletin of Faculty of Pharmacy, Cairo University
- Vol. 55 (2) , 203-210
Abstract
Drug discovery include drug designing and development, is a multifarious and expensive endeavor, where least number of drugs that pass the clinical trials makes it to market. Software based drug discovery and development methods have major role in the development of bioactive compounds for over last three decades. Novel software based methods such as molecular modeling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for investigation of pharmacokinetic and pharmacodynamic properties of drug, and structural activity relationship between ligand and its target. Computational approaches such as docking confer interaction of small molecules with structural macromolecules and thereby hit identification and lead optimization. These methods are faster, and accurately provide valuable insights of experimental findings and mechanisms of action. In addition, appropriate implementation of these techniques could lead to a reduction in cost of drug designing and development. Currently in biomedicine sciences these software are exhibiting imperative role in the different phases of drug discovery. The review discusses working principle and successful applications of most commonly used software for drug designing and development. Keywords: Drug discovery, Docking, Structural activity relationship, Molecular modeling, Computational methodKeywords
This publication has 17 references indexed in Scilit:
- Applying high-performance computing in drug discovery and molecular simulationNational Science Review, 2016
- Emerging role of bioinformatics tools and software in evolution of clinical researchPerspectives in Clinical Research, 2016
- A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System TargetsFrontiers in Neurology, 2015
- Molecular Docking and Structure-Based Drug Design StrategiesMolecules, 2015
- Model‐based clinical drug development in the past, present and future: a commentaryBritish Journal of Clinical Pharmacology, 2014
- The Discovery of Potentially Selective Human Neuronal Nitric Oxide Synthase (nNOS) Inhibitors: A Combination of Pharmacophore Modelling, CoMFA, Virtual Screening and Molecular Docking StudiesInternational Journal of Molecular Sciences, 2014
- Computational Methods in Drug DiscoveryPharmacological Reviews, 2014
- In Vitro–In Vivo Correlation of Efavirenz Tablets Using GastroPlus®AAPS PharmSciTech, 2013
- Challenges and advances in computational docking: 2009 in reviewJournal of Molecular Recognition, 2010
- Accuracy of Protein-Protein Binding Sites in High-Throughput Template-Based ModelingPLOS Computational Biology, 2010